Hiroyuki Ohnuma

4PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 24, 2021
Combination of psoas muscle mass index and neutrophil/lymphocyte ratio as a prognostic predictor for patients undergoing nonsurgical hepatocellular carcinoma therapy.

Yusuke Sugama, Koji Miyanishi, Takahiro Osuga

|Feb 03, 2021
Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis.

Hiroyuki Ohnuma, Yasushi Sato, Naoki Onoyama

|Aug 24, 2018
Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study.

Hiroyuki Ohnuma, Yasushi Sato, Naotaka Hayasaka

|Feb 01, 2018
Docetaxel, cisplatin and S-1 (DCS) combination chemotherapy for gastric cancer patients with peritoneal metastasis: a retrospective study.

Hiroyuki Ohnuma, Yasushi Sato, Masahiro Hirakawa

Pageof 1

Frequent Collaborators

1 joint publications

Koji Miyanishi

1 joint publications

Tomohiro Kubo

1 joint publications

Masayoshi Kobune

1 joint publications

Junji Kato